192 related articles for article (PubMed ID: 24510789)
1. Differentiation of hepatocytes from pluripotent stem cells.
Mallanna SK; Duncan SA
Curr Protoc Stem Cell Biol; 2013 Sep; 26():1G.4.1-1G.4.13. PubMed ID: 24510789
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of hepatocyte-like cells from human pluripotent stem cells using small molecules.
Asumda FZ; Hatzistergos KE; Dykxhoorn DM; Jakubski S; Edwards J; Thomas E; Schiff ER
Differentiation; 2018; 101():16-24. PubMed ID: 29626713
[TBL] [Abstract][Full Text] [Related]
3. iPSC-derived hepatocytes generated from NASH donors provide a valuable platform for disease modeling and drug discovery.
Gurevich I; Burton SA; Munn C; Ohshima M; Goedland ME; Czysz K; Rajesh D
Biol Open; 2020 Dec; 9(12):. PubMed ID: 33268331
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Modeling of Alcohol-Induced Liver Injury Using Human-Induced Pluripotent Stem Cells.
Tian L; Prasad N; Jang YY
Methods Mol Biol; 2016; 1353():271-83. PubMed ID: 25520290
[TBL] [Abstract][Full Text] [Related]
5. Semi-automated Production of Hepatocyte Like Cells from Pluripotent Stem Cells.
Meseguer-Ripolles J; Lucendo-Villarin B; Wang Y; Hay DC
J Vis Exp; 2018 Jul; (137):. PubMed ID: 30102283
[TBL] [Abstract][Full Text] [Related]
6. Stem cell-derived models to improve mechanistic understanding and prediction of human drug-induced liver injury.
Goldring C; Antoine DJ; Bonner F; Crozier J; Denning C; Fontana RJ; Hanley NA; Hay DC; Ingelman-Sundberg M; Juhila S; Kitteringham N; Silva-Lima B; Norris A; Pridgeon C; Ross JA; Young RS; Tagle D; Tornesi B; van de Water B; Weaver RJ; Zhang F; Park BK
Hepatology; 2017 Feb; 65(2):710-721. PubMed ID: 27775817
[TBL] [Abstract][Full Text] [Related]
7. Efficient Generation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells for Disease Modeling and Disease Gene Discovery.
Kumar S; Curran JE; Williams-Blangero S; Blangero J
Methods Mol Biol; 2022; 2549():85-101. PubMed ID: 33772461
[TBL] [Abstract][Full Text] [Related]
8. [Development of a Novel Hepatocyte Model Using Stem Cells for Pharmaceutical Research].
Toba-Ueyama Y
Yakugaku Zasshi; 2023; 143(11):905-909. PubMed ID: 37914337
[TBL] [Abstract][Full Text] [Related]
9. Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells.
Lucendo-Villarin B; Filis P; Swortwood MJ; Huestis MA; Meseguer-Ripolles J; Cameron K; Iredale JP; O'Shaughnessy PJ; Fowler PA; Hay DC
Arch Toxicol; 2017 Nov; 91(11):3633-3643. PubMed ID: 28510779
[TBL] [Abstract][Full Text] [Related]
10. Directed Differentiation of Pluripotent Stem Cells by Transcription Factors.
Oh Y; Jang J
Mol Cells; 2019 Mar; 42(3):200-209. PubMed ID: 30884942
[TBL] [Abstract][Full Text] [Related]
11. Concise Review: Advances in Generating Hepatocytes from Pluripotent Stem Cells for Translational Medicine.
Szkolnicka D; Hay DC
Stem Cells; 2016 Jun; 34(6):1421-6. PubMed ID: 27015786
[TBL] [Abstract][Full Text] [Related]
12. Human Stem Cell-Derived Endothelial-Hepatic Platform for Efficacy Testing of Vascular-Protective Metabolites from Nutraceuticals.
Narmada BC; Goh YT; Li H; Sinha S; Yu H; Cheung C
Stem Cells Transl Med; 2017 Mar; 6(3):851-863. PubMed ID: 28297582
[TBL] [Abstract][Full Text] [Related]
13. The efficient generation of functional human hepatocytes from chemically induced pluripotent stem cells.
Lv Y; Rao Z; Liu L; Jia J; Wu C; Xu J; Du Y; Liu Y; Liu B; Shi J; Li G; Zhao D; Deng H
Cell Prolif; 2024 Feb; 57(2):e13540. PubMed ID: 37814474
[TBL] [Abstract][Full Text] [Related]
14. Modeling human hepatic steatosis in pluripotent stem cell-derived hepatocytes.
Sinton MC; Meseguer-Ripolles J; Lucendo-Villarin B; Drake AJ; Hay DC
STAR Protoc; 2021 Jun; 2(2):100493. PubMed ID: 33997813
[TBL] [Abstract][Full Text] [Related]
15. Establishment of human induced pluripotent stem cell-derived hepatobiliary organoid with bile duct for pharmaceutical research use.
Wang L; Koui Y; Kanegae K; Kido T; Tamura-Nakano M; Yabe S; Tai K; Nakajima Y; Kusuhara H; Sakai Y; Miyajima A; Okochi H; Tanaka M
Biomaterials; 2024 Oct; 310():122621. PubMed ID: 38815455
[TBL] [Abstract][Full Text] [Related]
16. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.
Rashid ST; Corbineau S; Hannan N; Marciniak SJ; Miranda E; Alexander G; Huang-Doran I; Griffin J; Ahrlund-Richter L; Skepper J; Semple R; Weber A; Lomas DA; Vallier L
J Clin Invest; 2010 Sep; 120(9):3127-36. PubMed ID: 20739751
[TBL] [Abstract][Full Text] [Related]
17. Stem cell-derived liver cells for drug testing and disease modeling.
Davidson MD; Ware BR; Khetani SR
Discov Med; 2015 May; 19(106):349-58. PubMed ID: 26105698
[TBL] [Abstract][Full Text] [Related]
18. Generating hepatic cell lineages from pluripotent stem cells for drug toxicity screening.
Baxter MA; Rowe C; Alder J; Harrison S; Hanley KP; Park BK; Kitteringham NR; Goldring CE; Hanley NA
Stem Cell Res; 2010 Jul; 5(1):4-22. PubMed ID: 20483202
[TBL] [Abstract][Full Text] [Related]
19. Erratum to: Modelling foetal exposure to maternal smoking using hepatoblasts from pluripotent stem cells.
Lucendo-Villarin B; Filis P; Swortwood MJ; Huestis MA; Meseguer-Ripolles J; Cameron K; Iredale JP; O'Shaughnessy PJ; Fowler PA; Hay DC
Arch Toxicol; 2017 Nov; 91(11):3645. PubMed ID: 28980015
[TBL] [Abstract][Full Text] [Related]
20. Corrigendum: Patient-specific hepatocyte-like cells derived from induced pluripotent stem cells model pazopanib-mediated hepatotoxicity.
Choudhury Y; Toh YC; Xing J; Qu Y; Poh J; Li H; Tan HS; Kanesvaran R; Yu H; Tan MH
Sci Rep; 2017 Apr; 7():46391. PubMed ID: 28440337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
